News About: Pharm. Industry
It was identified that four out of five multinational pharmaceutical companies registered their category of business as medicine wholesale business
It was identified that four out of five multinational pharmaceutical companies registered their category of business as medicine wholesale business.
According to the analysis result of audit report of multinational p...
BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year
According to Korea Pharmaceutical Traders Association, BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year.
Baraclude 0.5mg recorded import of $ 8.183 million, followed by MSD's Gad...
Real investment cost used in the process of research and development of major domestic new drugs increased as the same level of advanced countries
According to the analysis of real investment cost used in the process of research and development of major domestic new drugs, 297.7 billion won was invested in the development process of the country's first global ne...
Listed and non-listed pharmaceutical companies’ annual sale per employee was 23 million won
According to the audit report of listed and non-listed pharmaceutical companies which is submitted to Financial Supervisory Service, it turned out that their annual sales per employee was 23 million won.
11 pharmaceu...
Revised bill of National Health Insurance Law (Illegal kickback Two-strike out system) could be in violation of principle of the proportion, and principle of prohibition of excess
On Apr 23, Attorney Lee, Seuk-Joon from Yulchon pointed out that revised bill of National Health Insurance Law (Illegal kickback Two-strike out system) could be in violation of principle of the proportion, principle o...
Multinational pharmaceutical companies’ annual salary per employee was 7.06 million won
According to the audit report of 36 multinational pharmaceutical companies in Korea, it was analyzed that their annual salary per employee was 7.06 million won.
According to the survey result, Johnson & Johnson Me...
Korea Pharmaceutical Manufacturers Association opposed to charge value-added tax on clinical trial conducted in hospital
National Tax Service and Ministry of Strategy and Finance decided to charge value-added tax on clinical trial conducted in hospital which is designated as clinical trial testing laboratory, and retroactively apply the...
The high drug price of Gilead’s Sovaldi has run into strong opposition of high number of insurance companies and government insurance system in America
On Apr 21, according to industry sources, Gilead quoted Sovaldi's price of $ 84,000 in America last December 2013. Gilead quoted high price with the reason of its high drug efficacy and low side effect compared to exi...
The average selling and administrative expenses to sales ratio of multinational pharmaceutical companies in Korea is 1.8% lower than that of domestic pharmaceutical companies
According to the audit report of 30 multinational pharmaceutical companies in Korea settled in December, average selling and administrative expenses to sales ratio of these pharmaceutical companies was average 31.5%. ...
The increase rate of sales of listed pharmaceutical companies is higher than that of non0listed pharmaceutical companies
According to the analysis of business performance of listed and non0listed pharmaceutical companies last year, 54 listed pharmaceutical companies recorded average sales of 196.1 billion won. 72 non0listed pharmaceutic...
